• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 98 of 100
Inside of a Gilead Sciences Lab
TechBigger drug discounts put question mark over Gilead’s stellar run
By Reuters and Fortune EditorsFebruary 4, 2015
Pharmacy technician Andrea Tibbetts counts out pills to fill an order for generic medications at Por
FinanceHow to save on your prescription meds (yep, there’s an app for that)
By Jean ChatzkyFebruary 3, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
FinanceAfter Allergan loss, is Valeant dumpster diving?
By Jen WiecznerJanuary 31, 2015
Key Speakers At Osons La France Economic Summit
LeadershipFire in haste, repent at leisure: Sanofi wonders why it can’t find a new CEO
By ReutersJanuary 30, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
FeaturesPfizer’s outlook disappoints as it struggles with patent expirations
By Laura LorenzettiJanuary 27, 2015
Regeneron vaults ahead of Amgen in race to market cholesterol drug
FeaturesRegeneron vaults ahead of Amgen in race to market cholesterol drug
By ReutersJanuary 26, 2015
Negatively-stained Hong Kong Flu Virus
FeaturesOne shot to cure them all: The quest for the universal flu shot
By Erika FryJanuary 21, 2015
Detroit auto show and Obama on cybersecurity — 5 things to know today
FeaturesDetroit auto show and Obama on cybersecurity — 5 things to know today
By Laura LorenzettiJanuary 12, 2015
Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer
Shire switches from target to predator with $5.2 billion NPS buy
By Geoffrey SmithJanuary 12, 2015
A powerful new super antibiotic may be right under our feet
TechA powerful new super antibiotic may be right under our feet
By Laura LorenzettiJanuary 8, 2015
Flu Outbreak Continues In Bay Area
RetailIt’s a bad flu season, but that’s good news for Walgreen
By Laura LorenzettiJanuary 6, 2015
Picture taken on January 15, 2012 in Lil
FeaturesThe U.S. has a drug shortage — and people are dying
By Mark KobaJanuary 6, 2015
J&J starts clinical trials of Ebola drug
J&J starts clinical trials of Ebola drug
By ReutersJanuary 6, 2015
Key Speakers At The Stanford Institute For Economic Policy Research Forum
LeadershipStep aside Wall Street, small pharma CEO pay reaches for the sky
By Paul HodgsonJanuary 5, 2015
Health workers in protective equipment handle a sample taken from the body of someone who is suspected to have died from Ebola virus, near Rokupa Hospital
FeaturesRoche wins FDA emergency approval for Ebola test
By Laura LorenzettiDecember 29, 2014
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
Environment
Trump, who has repeatedly called climate change fake, is now threatening Brazil with tariffs over the deforestation of the Amazonplaceholder alt text
By Sasha RogelbergJune 8, 2026
Personal Finance
Current price of oil as of June 8, 2026placeholder alt text
By Joseph HostetlerJune 8, 2026
Asia
Pentagon accuses Alibaba, Baidu and BYD, three of China's biggest companies, of supporting the Chinese militaryplaceholder alt text
By Kate O'Keeffe and BloombergJune 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.